Miren Etchetto (Miren Ettcheto)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 21

Top Venues

Pharmaceutics

Cell & bioscience

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Universitat de Manresa

Universitat de Barcelona (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat de Manresa Sep 1o 2019

Spain

Profesora colaboradora :: Farmacología

Education History

Universitat de Barcelona Sep 17o 2012 - Jul 30o 2013

Spain

MSC

Publications

Triana Espinosa-Jiménez, Amanda Cano, Elena Sánchez-López, Jordi Olloquequi, Jaume Folch, Mònica Bulló, Ester Verdaguer, Carme Auladell, Caterina Pont, Diego Muñoz-Torrero, Antoni Parcerisas, Antoni Camins, Miren Etchetto
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet. Cell & bioscience 13 (1) (2023)
Triana Espinosa-Jiménez, Amanda Cano, Elena Sánchez-López, Jordi Olloquequi, Jaume Folch, Mònica Bulló, Ester Verdaguer, Carme Auladell, Caterina Pont, Diego Muñoz-Torrero, Antoni Parcerisas, Antoni Camins, Miren Etchetto
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet. Cell & bioscience 13 (1) (2023)
Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez-Lopez, Miren Etchetto, Eliana Barbosa Souto, Antonio Camins Espuny, Mercè Boada, Agustin Ruiz
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics 15 (1) (2023)
Triana Espinosa-Jiménez, Amanda Cano, Elena Sánchez-López, Jordi Olloquequi, Jaume Folch, Mònica Bulló, Ester Verdaguer, Carme Auladell, Caterina Pont, Diego Muñoz-Torrero, Antoni Parcerisas, Antoni Camins, Miren Etchetto
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet. Cell & bioscience 13 (1) (2023)
Jordi Olloquequi, Miren Etchetto, Amanda Cano, Ana Fortuna, Joana Bicker, Elena Sánchez-Lopez, Cristian Paz, Jesús Ureña, Ester Verdaguer, Carme Auladell, Antonio Camins Espuny
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment. International journal of molecular sciences 24 (18) (2023)
Triana Espinosa-Jiménez, Amanda Cano, Elena Sánchez-López, Jordi Olloquequi, Jaume Folch, Mònica Bulló, Ester Verdaguer, Carme Auladell, Caterina Pont, Diego Muñoz-Torrero, Antoni Parcerisas, Antoni Camins, Miren Etchetto
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet. Cell & bioscience 13 (1) (2023)
Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez-Lopez, Miren Etchetto, Eliana Barbosa Souto, Antonio Camins Espuny, Mercè Boada, Agustin Ruiz
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics 15 (1) (2023)
Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez-Lopez, Miren Etchetto, Eliana Barbosa Souto, Antonio Camins Espuny, Mercè Boada, Agustin Ruiz
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics 15 (1) (2023)
Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez-Lopez, Miren Etchetto, Eliana Barbosa Souto, Antonio Camins Espuny, Mercè Boada, Agustin Ruiz
Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges. Pharmaceutics 15 (1) (2023)
Ruth Galindo, Elena Sánchez-Lopez, María José Gómara, Marta Espina, Miren Etchetto, Amanda Cano, Isabel Haro, Antonio Camins Espuny, María Luisa García
Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation. Pharmaceutics 14 (2) (2022)
Victor García-Torra, Amanda Cano, Marta Espina, Miren Etchetto, Antonio Camins Espuny, Emma Barroso, Manuel Vázquez-Carrera, Maria Luisa García, Elena Sánchez-Lopez, Eliana Barbosa Souto
State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks. Toxics 9 (8) (2021)
Miren Etchetto, Amanda Cano, Elena Sanchez-López, Ester Verdaguer, Jaume Folch, Carme Auladell, Antonio Camins Espuny
Masitinib for the treatment of Alzheimer's disease. Neurodegenerative disease management 11 (4) (2021)
Claudia Taborda Gómez, Fabiana Lairion, Marisa Repetto, Miren Etchetto, Amalia Merelli, Alberto Lazarowski, Jerónimo Auzmendi
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Lorena Bonilla, Marta Espina, Patrícia Severino, Amanda Cano, Miren Etchetto, Antonio Camins Espuny, Maria Luisa García, Eliana Barbosa Souto, Elena Sánchez-Lopez
Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics 14 (1) (2021)
Amanda Cano, Elena Fonseca, Miren Etchetto, Elena Sánchez-Lopez, Itziar de Rojas, Silvia Alonso-Lana, Xavier Morató, Eliana Barbosa Souto, Manuel Toledo, Mercè Boada, Marta Marquié, Agustín Ruíz
Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Rubén Darío Castro-Torres, Jordi Olloquequi, Miren Etchetto, Pablo Caruana, Luke Steele, Kyra-Mae Leighton, Jesús Ureña, Carlos Beas-Zarate, Antonio Camins Espuny, Ester Verdaguer, Carme Auladell
Dual Mkk4 and Mkk7 Gene Deletion in Adult Mouse Causes an Impairment of Hippocampal Immature Granule Cells. International journal of molecular sciences 22 (17) (2021)
Saghar Rabiei Poor, Miren Etchetto, Amanda Cano, Elena Sánchez-Lopez, Patricia Regina Manzine, Jordi Olloquequi, Antonio Camins Espuny, Mohammad Javan
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Miren Etchetto, Elena Sánchez-Lopez, Amanda Cano, Marina Carrasco, Katherine Herrera, Patricia R Manzine, Triana Espinosa-Jimenez, Oriol Busquets, Ester Verdaguer, Jordi Olloquequi, Carme Auladell, Jaume Folch, Antoni Camins
Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer's disease in metabolically stressed APPswe/PS1dE9 mice. Cell & bioscience 11 (1) (2021)
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz-Bouet, Pedro Cisternas, Carolina A Oliva, Elena Sánchez-López, Miren Etchetto, Manuela Bartolini, Angela De Simone, Mattia Ricchini, Marisa Rendina, Mégane Pons, Omidreza Firuzi, Belén Pérez, Luciano Saso, Vincenza Andrisano, Florian Nachon, Xavier Brazzolotto, Maria Luisa García, Antoni Camins, Israel Silman, Ludovic Jean, Nibaldo C Inestrosa, Jacques-Philippe Colletier, Pierre-Yves Renard, Diego Muñoz-Torrero
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. Journal of medicinal chemistry 64 (1) (2020)
Elena Sánchez-Lopez, Gerard Esteruelas, Alba Ortiz, Marta Espina, Josefina Prat, Montserrat Muñoz, Amanda Cano, Ana-Cristina Calpena-Campmany, Miren Etchetto, Antonio Camins Espuny, Zaid Alsafi, Eliana Barbosa Souto, Maria Luisa García, Montserrat Pujol
Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study. Nanomaterials (Basel, Switzerland) 10 (4) (2020)
Rubén Darío Castro-Torres, Oriol Busquets, Antoni Parcerisas, Ester Verdaguer, Jordi Olloquequi, Miren Etchetto, Carlos Beas-Zarate, Jaume Folch, Antonio Camins Espuny, Carme Auladell
Involvement of JNK1 in Neuronal Polarization During Brain Development. Cells 9 (8) (2020)

Miren Etchetto.css-eqlu8i{font-size:small;padding-left:4px;} (Miren Ettcheto)

Publication Activity (10 Years)

Top Topics

Top Venues

Miren Etchetto (Miren Ettcheto)